Heyu Biological Technology Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
For the nine months, sales was USD 0.028968 million compared to USD 0.078397 million a year ago. Net loss was USD 0.144376 million compared to USD 0.140938 million a year ago.